![Benzyl N-[2-(prop-2-enamido)ethyl]carbamate](https://file.medchemexpress.com/product_pic/hy-w800833.gif "Click to View Benzyl N-[2-(prop-2-enamido)ethyl]carbamate Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
75 Results for "
acrylamide
" in MedChemExpress (MCE) Product Catalog:
Products (75)
75 Results for "acrylamide" in MCE Product Catalog:
Cat. No.: HY-144050
CAS No.: 2711105-59-6
EGFR-IN-33 is a potent inhibitor of EGFR. EGFR-IN-33 is an anti-tumor agent with low toxic side effects. EGFR-IN-33 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-33 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 13) .
Cat. No.: HY-144051
EGFR-IN-34 is a potent inhibitor of EGFR. EGFR-IN-34 is an anti-tumor agent with low toxic side effects. EGFR-IN-35 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-34 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 12) .
Cat. No.: HY-144052
CAS No.: 2711105-57-4
EGFR-IN-35 is a potent inhibitor of EGFR. EGFR-IN-35 is an anti-tumor agent with low toxic side effects. EGFR-IN-35 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-35 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 11) .
Cat. No.: HY-144054
CAS No.: 2711105-53-0
EGFR-IN-37 is a potent inhibitor of EGFR. EGFR-IN-37 is an anti-tumor agent with low toxic side effects. EGFR-IN-39 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-37 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 7) .
Cat. No.: HY-144055
CAS No.: 2711105-50-7
EGFR-IN-38 is a potent inhibitor of EGFR. EGFR-IN-38 is an anti-tumor agent with low toxic side effects. EGFR-IN-33 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-38 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 4) .
Cat. No.: HY-144056
CAS No.: 2711105-48-3
EGFR-IN-39 is a potent inhibitor of EGFR. EGFR-IN-39 is an anti-tumor agent with low toxic side effects. EGFR-IN-39 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-39 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 2) .
Cat. No.: HY-P1321A
Synonyms: 1229U91 TFA; GW1229 TFA
Target:
Domaines de recherche:
Cat. No.: HY-W710827
Cat. No.: HY-W1052238
Synonyms: 8-Arm-PEG10000-ACA
Cat. No.: HY-W1052238A
Synonyms: 8-Arm-PEG20000-ACA
Cat. No.: HY-W1052238B
Synonyms: 8-Arm-PEG40000-ACA
Cat. No.: HY-188124
(E)-N-(8-Aminooctyl)-3-(pyridin-3-yl) acrylamide is a ligand linker targeting NAMPT, which can be used to synthesize PROTEC NAMPT Degrader-1 (HY-189001). (E)-N-(8-Aminooctyl)-3-(pyridin-3-yl) acrylamide is applicable to the research of ovarian cancer .
Cat. No.: HY-135721
CAS No.: 13304-62-6
Synonyms: Benzyl acrylamide
Target:
Domaines de recherche:
N-Benzylacrylamide (Benzyl acrylamide) is a hydrophobic monomer. N-Benzylacrylamide can form hydrophobic microdomains that act as physical cross-linking sites to connect polymer chains to each other into a three-dimensional network; dynamically reversible hydrophobic interactions enable the spontaneous reformation of physical cross-linking sites after contact of fractured surfaces, thereby achieving autonomous self-healing. N-Benzylacrylamide can promote the synthesis of carboxymethyl cellulose-modified amphiphilic copolymers, and enhance the intermolecular association, viscoelasticity, thermal stability, as well as fire resistance/fire extinguishing performance of the resulting hydrogels .
Cat. No.: HY-W543655
CAS No.: 2828433-64-1
(2E,2'E)-N,N'-(1,4-Phenylenebis(methylene))bis(3-(pyridin-4-yl)acrylamide) is a metal-organic framework (MOF).
Cat. No.: HY-W714541
CAS No.: 168208-30-8
Target:
Domaines de recherche:
N-Acetyl-S-(2-cyanoethyl) -L-cysteine ammonium salt is the urinary metabolite of acrylamide in vivo.
Cat. No.: HY-W017180
CAS No.: 72707-66-5
Synonyms: α-(Bromomethyl)acrylic acid; α-Methylated acrylamide; α-MAA
Target:
Domaines de recherche:
2-(Bromomethyl) acrylic acid (α-MAA) is a component of Ibt-DOX (HY-181546) .
Cat. No.: HY-W587436
CAS No.: 81690-92-8
Target:
Domaines de recherche:
N-Acetyl-S-(2-carbamoylethyl) -L-cysteine is the urinary metabolite of acrylamide in humans, and its association with other diseases.
Cat. No.: HY-W800833
CAS No.: 55946-27-5
Target:
Domaines de recherche:
Benzyl N-[2-(prop-2-enamido)ethyl]carbamate is a short aliphatic linker featuring a Cbz-protected amine and an acrylamide. Acrylamide is a Michael acceptor which is a good Michael acceptor which can be used in thiol-based bioconjugation or polymerization. Meanwhile, the Cbz protecting group can be removed using Pd-C hydrogenation to reveal a free amine that can participate in a wide variety of reactions such as couplings or reductive amination.
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
